Muscle, tendon and ligament injuries
SeenFaster healing in injured rats.
Not shownAny of it in people. 35 of 36 studies in a 2025 review were not in humans.
Clinician-guided careFree & fast shipping
Skip to contentBPC-157explained.
Also called bepecin or PL 14736.
Be first to know.Email the day BPC-157's FDA or HHS status changes.
Updates only. Doesn't reserve treatment. Unsubscribe anytime. Privacy
Is it legal?Not FDA approved
HHS won't block pharmacies. FDA hasn't approved it.
- Done: Off Category 2
- Done: Panel voted 8 to 6
- Done: HHS lets pharmacies compound
- Not yet: FDA approved
Source: FDA and HHSChecked Oct 29, 2026
15amino acids5small human studies0FDA approvalsS0banned in sport
A chain of 15.
A lab-made string of 15 amino acids. It's a piece of a bigger protein first found in stomach juice.
123456789101112131415
What it does in the body
Nobody knows yet. FDA says its targets in the body are unknown and no one has worked out a dose.
How it's been given
EnemaKnee shotInto the bladderIV drip
What it's being studied for.
Studied for is not proven. The bars show how far the research has gone.
Ulcerative colitis
SeenRats were protected from colon, stomach and liver damage. One human trial of 53 people exists only as a meeting abstract.
Not shownFDA called the colitis data inadequate to show it works or is safe.
Knee pain
Seen17 people got 1 or 2 shots. A separate look back at 12 people found 7 said they felt better.
Not shownToo few people to say it works. Safety in people is still unknown.
Bladder pain (interstitial cystitis)
Seen12 people, one 10 mg dose put into the bladder.
Not shownToo small and too short to tell if it helps.
No large human trial exists for anything on this list.
The research.
Every study we cite, with where to read it.
Screened 544 papers and kept 36. Only 1 was in people: 12 people given knee shots, looked at after the fact.It found that safety in people is still unknown.Vasireddi N, et al. HSS Journal, 2025.Read on PubMed Central
Enema, 8 days24 healthy adults
Enema, 2 weeks53 with colitis (abstract)
Knee shot, 1 or 2 doses17 with knee pain
Into the bladder, once12 with bladder pain
IV drip, 2 days2 people
Rat studies showed protection from colon fistulas and stomach and liver damage.FDA noted the work was only in rodents and nobody has set a dose. It also found 3 side effect reports where the cause was unclear.FDA presentation, Jul 23, 2026
Where FDA stands.
FDA says it will take BPC-157 off Category 2 after its nominator withdrew it.
FDA's Category 2 page shows the change.
FDA staff advised against it. The advisory panel voted 8 to 6 for it anyway.
An interim peptide policy went to the White House for review.
HHS filed that policy. It won't act against state-licensed pharmacies or licensed doctors that compound BPC-157 while the 503A list goes through rulemaking. It runs in the Federal Register on Oct 30.
A formal rule to put it on the 503A list. No date yet. FDA approval is a separate process, and nobody has applied.
The voteThe panel only advises. Adding BPC-157 to the 503A list takes a formal rule change.
The new policyHHS can drop it if a safety or quality problem shows up. Compounded drugs still aren't FDA approved, and FDA doesn't check them for safety or for whether they work.
HHS policy, filed Oct 28, 2026 What FDA flaggedIn 28-day rat and dog studies, clotting times shifted and liver enzymes, blood sugar and triglycerides went up.
FDA says it may carry a significant risk of immune reactions, mostly by shot or nasal spray. No study has tested this.
Impurities and clumping are a concern. The lab reports FDA saw left out impurity and contamination testing.
FDA raised a theoretical concern that it could help tumor cells grow or spread. This has not been shown in people.
No cancer studies and no full pregnancy or fertility studies were found.
The World Anti-Doping Agency lists it under S0, banned at all times.
Sold online as "research use only"? That label means the seller says it's not for people. No prescriber, no pharmacy check.
Keep reading.
LegalAre peptides legal?
FDA categories, sorted outGuideThe Sommar Peptide Guide
Start here
Same shelfFDA categories, sorted outGuideThe Sommar Peptide Guide
Start here
vsBPC-157 vs TB-500
Coming Fri Oct 30
Coming Fri Oct 30
Asked a lot.
It came off Category 2 in Apr 2026 and an FDA panel voted 8 to 6 for it in Jul 2026. On Oct 28, 2026, HHS filed a policy saying it won't act against licensed pharmacies and doctors that compound it while the 503A list goes through rulemaking. It still isn't on the 503A list, and FDA hasn't approved it for any use.
No. FDA found no approved product that contains it.
Nobody knows well in people. The human studies were small and short. In animals, FDA flagged clotting and liver signals.
No. The panel advises. FDA hasn't decided, and the list only changes through a formal rule.
Yes. WADA bans it at all times under S0.
Peptide waitlist
Be first to know.
Get an email the day BPC-157's FDA or HHS status changes. Updates are for education only. Joining doesn't reserve treatment.
Email only. Please don't share health details here. Privacy Policy